Skip to main content
Clinical Trials/NCT06897553
NCT06897553RecruitingNot Applicable

Acceptance and Commitment Therapy- Based Group Therapy for Mental Health in Neurological Disorders

Bielefeld University1 site in 1 country44 target enrollmentStarted: December 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
44
Locations
1
Primary Endpoint
Depression and Anxiety Stress Scales-21 (Lovibond, 1995)

Study Overview

Brief Summary

The goal of this clinical trial is to examine the efficacy of this manual for mental health in people with mixed neurological disorders, including post-COVID. These conditions are often associated with cognitive impairment, which may hamper the effects of psychoterapy. Executive functioning and especially the ability to abstract thinking may be useful for individuals using Acceptance and Commitment Therapy. Therefore, the main questions research questions are:

  • Is this intervention effective in improving mental health?
  • Do executive functions predict the extent of social participation and mental health at the end of therapy? Participants will take part in 8 weekly group therapy sessions of 100 minutes each.

Detailed Description

Mental health issues, especially depression, anxiety, and stress, are common in people with neurological disorders and post-COVID but often neglected and hence, remain untreated. Acceptance and Commitment Therapy (ACT) is a promising approach to assist people in adapting to their conditions by improving "psychological flexibility".

A previous study translated an adapted group psychotherapy manual for stroke survivors into German and demonstrated its feasibility. This pilot study also gave first indications on the manual's efficacy in reducing symptoms of anxiety, depression, and stress. The aim of this study is to investigate the efficacy of this ACT-based group therapy. People with neurological disorders may have impairments in executive functions, which can affect the psychotherapeutic process. Since ACT often uses metaphors and imagery, executive functions, particularly the ability to abstract, could influence the efficacy of the therapy and are therefore being investigated in this study. The program includes 8 weekly sessions with a session length of 100 minutes.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Value above a cut-off of the DASS-21 subscales (depression > 10, anxiety > 6, and stress > 10)
  • •Sufficient cognition and language ability (clinical rating)
  • •Sufficient therapy motivation (clinical rating)

Exclusion Criteria

  • •Behavioral disorders (e.g., high irritability or apathy in clinical rating)
  • •Other severe mental disorder (dementia, psychosis, personality disorders, intellectual disability)
  • •Simultaneous psychotherapy or neuropsychological therapy

Arms & Interventions

Waiting List and ACT group therapy

Experimental

Eight weeks of waiting list are followed by eight weeks of ACT group therapy, see study design.

Intervention: ACT-based group therapy (Behavioral)

Outcomes

Primary Outcomes

Depression and Anxiety Stress Scales-21 (Lovibond, 1995)

Time Frame: Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart)

Measure of psychological burden to investigate efficacy. Scores range from 0 to 63 with higher values indicating higher burden.

Acceptance and Action Questionnaire-Acquired Brain Injury (Sylvester, 2011)

Time Frame: Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart)

Measure of psychological flexibility to investigate efficacy. Scores range from 0 to 36 with higher values indicating higher inflexibility.

Wechsler Adult Intelligence Scale - Fourth Edition (Similarities subtest; Wechsler, 2008)

Time Frame: pre- and post-intervention (pre and post are presumably 8 weeks apart)

Measure of individual's ability to recognize and articulate the commonalities between different objects, reflecting their abstraction ability. This will be used to examine the influence of the ability of abstract thinking. Scores range from 0 to 36 with higher values indicating higher ability of abstraction.

Secondary Outcomes

  • Valuing Questionnaire (Smout, 2014)(Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart))
  • Self-as-context scale (Zettle, 2018)(Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart))
  • World Health Organization Disability Assessment Schedule 2.0 (V.S. Üstün, 2010; Plain German)(Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart))
  • Regensburg Word Fluency Test (Aschenbrenner, 2001)(pre- and post-intervention (pre and post are presumably 8 weeks apart))
  • Stroop Test in Vienna Test System (Müller & Ziegler, 2001)(pre- and post-intervention (pre and post are presumably 8 weeks apart))
  • Patient Health Questionnaire-9 (Kroenke, 2001)(Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart))
  • Generalized Anxiety Disorder Scale-7 (GAD-7; Spitzer et al., 2007)(Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart))

Investigators

Sponsor
Bielefeld University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Simon Ladwig

Research Fellow (Post-Doc)

Bielefeld University

Study Sites (1)

Loading locations...

Similar Trials